Document Type
Article
Publication Date
Spring 5-2-2014
Abstract
We read the article by Miguel et al1 regarding Purtscher’s and Purtscher-like retinopathies with great interest. As the authors well describe, ‘Purtscher-like retinopathy’ is diagnosed in patients with fundus findings similar to Purtscher’s retinopathy, without a history of trauma but with known systemic associations.1 Current proposed mechanisms for the underlying pathogenesis include leukocyte aggregation by activated complement factor 5 (C5a).2 As noted by the authors’ systematic review, there is currently no established treatment for Purtscher-like retinopathy, although the literature consists of several case reports of treatment with corticosteroids, without certainty as to effect on the clinical course.1 Herein, we report for the first time a case of Purtscher-like retinopathy treated successfully with intravitreal bevacizumab injection.
Recommended Citation
Nesmith B, Bitar MS, Schaal S. The anatomical and functional benefit of bevacizumab in the treatment of macular edema associated with purtscher-like retinopathy. Eye. 2014;28:1038-1040. http://dx.doi.org/10.1038/eye.2014.85
Comments
This correspondence is provided as an open access link by the publisher. Copyright © 2014 The Royal College of Ophthalmologists. All rights reserved.